Key figures 2023 · Financial calendar · Financial publications · Annual General Meeting · Annual Press and Analyst Conference · Company Presentations.
We were founded in 1996 by a family seeking a cure for their daughter's pulmonary arterial hypertension, or PAH. Today, we have six FDA-approved therapies that ...
The Investor Relations website contains information about Aerovate Therapeutics, Inc.'s business for stockholders, potential investors, and financial ...
People also ask
What is the difference between Porsche SE and Porsche AG?
The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ ...
Aktie · Kennzahlen 2023 · Finanzkalender · Finanzpublikationen · Hauptversammlung · Bilanzpresse- und Analystenkonferenz · Unternehmenspräsentationen.
Events & Presentations · Stock Information · Analyst ... Investor FAQs IR Contact Email Alerts Proxy Online ... pulmonary arterial hypertension (PAH). Liquidia ...
The Investor Relations website contains information about Gossamer Bio's business for stockholders, potential investors, and financial analysts.
The Investor Relations website contains information about Keros Therapeutics's business for stockholders, potential investors, and financial analysts.
The Investor Relations website contains information about Pulmonx Corporation's business for stockholders, potential investors, and financial analysts.
The Pulmonary Hypertension Association is a community of over 16000 pulmonary hypertension patients, caregivers, and healthcare professionals.